Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Gasoline Fund Lp
UGA
No Data
LifeSci Capital Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $230
Inhibrx Biosciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 EPS Results.
Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Raises Target Price to $325
Stifel Nicolaus Sticks to Their Buy Rating for Inhibrx Biosciences Inc (INBX)
Express News | Inhibrx Biosciences Inc : Stifel Raises Target Price to $325 From $300
Inhibrx Biosciences GAAP EPS of -$2.15